Konferenzschrift | Kongress
Basis for variability of response to anti-rheumatic drugs : proceedings of a satellite meeting of the Xth Internat. Congress of Pharmacology, held in Sydney, Australia, August 20 - 22, 1987
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783764319595
3764319593
9780817619596
0817619593
- Maße
-
24 cm
- Umfang
-
XVI, 267 S.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Literaturangaben
- Erschienen in
-
Agents and actions ; Vol. 24[...]
- Schlagwort
-
Antirheumatikum
Wirkung
Antirheumatika
Antirheumatikum
- Ereignis
-
Veröffentlichung
- (wo)
-
Basel, Boston, Berlin
- (wer)
-
Birkhäuser
- (wann)
-
1988
- Beteiligte Personen und Organisationen
-
Brooks, Peter
International Congress on Pharmacology (10 : 1987 : Sydney)
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
- Kongress
Beteiligte
- Brooks, Peter
- International Congress on Pharmacology (10 : 1987 : Sydney)
- Birkhäuser
Entstanden
- 1988
Ähnliche Objekte (12)
The Effect of Anti-rheumatic Drugs on the Skeleton
Variability in response to anti-rheumatic drugs
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
Anti-rheumatic property and physiological safety of KMU-11342 in in vitro and in vivo models
Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents
The Effect of Anti-rheumatic Drugs on the Skeleton
Variability in response to anti-rheumatic drugs
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
Anti-rheumatic property and physiological safety of KMU-11342 in in vitro and in vivo models
Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents
The Effect of Anti-rheumatic Drugs on the Skeleton
Variability in response to anti-rheumatic drugs
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
Anti-rheumatic property and physiological safety of KMU-11342 in in vitro and in vivo models
Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients